歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

已收盘 03-30 16:08:20

16.830

-0.030

-0.18%

最高16.910	最低16.150	成交量108.27万
今开16.150	昨收16.860	日振幅4.51%
总市值178.57亿	流通市值178.57亿	总股本10.61亿
成交额1,802万	换手率0.10%	流通股本10.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":16.83,"timestamp":1774858100003,"preClose":16.86,"halted":0,"volume":1082693,"delay":0,"changeRate":-0.0017793594306050498,"floatShares":1061000000,"shares":1061000000,"eps":-0.300458,"marketStatus":"已收盘","change":-0.03,"latestTime":"03-30 16:08:20","open":16.15,"high":16.91,"low":16.15,"amount":18019605,"amplitude":0.045077,"askPrice":16.92,"askSize":5000,"bidPrice":16.83,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.267,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774920600000},"marketStatusCode":5,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":16.86,"openAndCloseTimeList":[[1774834200000,1774843200000],[1774846800000,1774857600000]],"volumeRatio":0.298057,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2620428166","title":"歌礼制药-B(01672)：口服小分子胰淀素受体激动剂ASC39在临床前模型中显示出类似eloralintide的胰淀素选择性与疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2620428166","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620428166?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:48","pubTimestamp":1773740894,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，本公司董事会宣布已选定对胰淀素具有选择性的强效口服小分子胰淀素受体激动剂ASC39作为临床开发候选药物。这些数据表明，相较于hCTR， ASC39对hAMY1R具有高度选择性，且ASC39对hAMY1R的选择性与eloralintide 相当。ASC39与eloralintide对hAMY1R的选择性比对hCTR的分别高40倍和64倍。在一项头对头饮食诱导肥胖大鼠研究中，与接受安慰剂给药的肥胖大鼠相比，ASC39每日口服给药显示出具有统计学显著性的体重下降，与eloralintide相当(见表1)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1515","BK1191","01477","BK1574","BK1161"],"gpt_icon":0},{"id":"1104277630","title":"歌礼制药-B计划于2026年第三季度向美国FDA提交ASC39口服片剂新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1104277630","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104277630?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:48","pubTimestamp":1773740893,"startTime":"0","endTime":"0","summary":"歌礼制药-B近日披露重要研发进展，公司计划在2026年第三季度向美国食品药品监督管理局提交ASC39口服片剂的新药临床试验申请。这一时间节点的明确标志着该创新药物研发进程进入关键阶段，为后续临床开发奠定重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2618948106","title":"每日卖空追踪 | 歌礼制药-B 03月11日卖空量成交25.6万股，卖空比例为6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948106","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618948106?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217824,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间03月11日，涨1.79%，卖空量成交25.6万股，较上一交易日减少15.51%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163251a6b7940d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163251a6b7940d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","01477","01672","BK1574"],"gpt_icon":0},{"id":"2618948459","title":"歌礼制药-B03月11日获主力加仓439.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948459","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618948459?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216921,"startTime":"0","endTime":"0","summary":"03月11日, 歌礼制药-B股价涨1.79%，报收15.37元，成交金额6377.4万元，换手率0.38%，振幅9.14%，量比1.41。歌礼制药-B今日主力资金净流入439.1万元，上一交易日主力净流入63.3万元。该股近5个交易日上涨8.52%，主力资金累计净流入326.6万元；近20日主力资金累计净流入3231.7万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161617a6b7860c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161617a6b7860c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1574","01672","01477","BK1161"],"gpt_icon":0},{"id":"1117776127","title":"歌礼制药Asc30临床试验取得突破：完成三月期给药后，第16周实现7.5%的安慰剂校正平均减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1117776127","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117776127?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:08","pubTimestamp":1773137329,"startTime":"0","endTime":"0","summary":"在最新公布的临床数据中，歌礼制药旗下代谢性疾病候选药物Asc30展现出显著疗效。研究显示，受试者在接受为期三个月的每月一次给药方案后，至第16周时，经安慰剂校正的平均体重下降幅度达到7.5%。这一结果不仅凸显了该药物在体重管理领域的潜力，也为后续临床开发提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"1101106955","title":"歌礼制药公布其长效皮下注射小分子GLP-1R激动剂ASC30用于肥胖症的美国II期24周研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1101106955","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101106955?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:02","pubTimestamp":1773136974,"startTime":"0","endTime":"0","summary":"歌礼制药宣布其针对肥胖症的超长效皮下储库型小分子GLP-1受体激动剂ASC30在美国开展的II期临床试验中取得积极顶线结果。该研究为期24周，评估了ASC30制剂的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2618936547","title":"歌礼制药-B(01672)：小分子GLP-1R激动剂ASC30的超长效皮下储库型制剂针对肥胖适应症的美国II期24周研究获积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618936547","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618936547?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:52","pubTimestamp":1773136372,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，该公司小分子GLP-1受体 激动剂ASC30皮下储库型制剂针对肥胖适应症的美国II期24周研究 取得积极顶线结果。ASC30皮下储库型制剂A2此前尚未开展过人体研究。ASC30皮下储库型制剂A1在末次给药后的16周维持期内均达到了治疗性药物暴露水平。这些结果显示ASC30皮下储库型制剂 A1有望成为每季度给药一次的有效减重维持疗法。ASC30皮下储库型制剂A1和A2安全性和耐受性良好，其安全性和耐受性特征和 GLP-1类药物一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4144","BK4590","01477","01672","BK1161","BK1515","BK1574","GLP"],"gpt_icon":0},{"id":"2618868209","title":"歌礼制药-B盘中异动 大幅拉升5.09%报15.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618868209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618868209?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:12","pubTimestamp":1773108737,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘10时12分，歌礼制药-B股票出现波动，股价快速拉升5.09%。截至发稿，该股报15.480港元/股，成交量61.6万股，换手率0.06%，振幅10.39%。资金方面，该股资金流入383.254万港元，流出213.845万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为4.69%。其相关个股中，百奥赛图-B、康方生物、来凯医药-B涨幅较大，振幅较大的相关个股有百奥赛图-B、轩竹生物-B、科济药业-B，振幅分别为16.68%、13.65%、13.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310101217a6b3defd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310101217a6b3defd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","01672","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2618193621","title":"每日卖空追踪 | 歌礼制药-B 03月09日卖空量成交8.5万股，卖空比例为3.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618193621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618193621?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045024,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间03月09日，涨2.29%，卖空量成交8.5万股，较上一交易日减少64.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163302a6b1c697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163302a6b1c697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01672","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2618621177","title":"歌礼制药-B盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618621177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618621177?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:30","pubTimestamp":1773019848,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时30分，歌礼制药-B股票出现波动，股价急速下挫5.00%。截至发稿，该股报13.680港元/股，成交量1.5万股，换手率0.00%，振幅3.96%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。歌礼制药-B股票所在的生物技术行业中，整体跌幅为1.79%。歌礼制药-B公司简介：歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909304897aa9990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909304897aa9990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1191","BK1574","BK1515","01672","BK1161"],"gpt_icon":0},{"id":"1191158198","title":"港股异动 | 创新药概念股走强，科伦博泰生物-B、歌礼制药-B涨超7%，恒瑞医药、康方生物涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191158198","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191158198?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:32","pubTimestamp":1772677926,"startTime":"0","endTime":"0","summary":"3月5日，创新药概念股走强，$科伦博泰生物-B(06990)$、$歌礼制药-B(01672)$涨超7%，$恒瑞医药(01276)$、$康方生物(09926)$涨超6%","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"be7091872f1e44aea2b2c791b8b6184f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU1997244956.HKD","LU2097828631.EUR","BK1515","LU0348825331.USD","LU2399975544.HKD","LU2476274308.USD","LU2495084118.USD","01672","LU2580892862.HKD","LU0348735423.USD","LU1820825898.SGD","LU0540923850.HKD","LU2488822045.USD","BK0060","LU1255011170.USD","LU0359201612.USD","BK0183","LU0634319403.HKD","BK4585","BK0028","LU0196878994.USD","BK1191","LU1781817850.SGD","LU2097828557.USD","LU1997245094.SGD","LU2543165471.USD","LU1146622755.USD","BK0012","LU0348784397.USD","LU1023057109.AUD","IE00BPRC5H50.USD","BK4588","LU2778985437.USD","BK0239","LU0359202008.SGD","LU1997245177.USD","06990","09926","IE00B5MMRT66.SGD","LU0348783233.USD","LU1794554557.SGD","LU0417516738.SGD","LU0405327494.USD","LU2097828805.USD","LU1720050803.USD","LU0561508036.HKD","LU1961090484.USD","LU1969619763.USD","LU0359201885.HKD","LU0348827113.USD","LU2097828714.EUR","LU0417516571.SGD","LU1064131003.USD","LU0405327148.USD","LU2097828474.EUR","LU2580892789.USD","LU2476274720.SGD","IE00B543WZ88.USD","LU2328871848.SGD","LU1328615791.USD","LU2289578879.USD","BK1161","LU1580142542.USD","BK0188","LU0348766576.USD","BK1574","LU2148510915.USD","LU0417516902.SGD","LU1064130708.USD","LU0348767384.USD","LU1655091616.SGD"],"gpt_icon":0},{"id":"2616510655","title":"每日卖空追踪 | 歌礼制药-B 03月04日卖空量成交30.7万股，卖空比例为9.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616510655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616510655?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613023,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间03月04日，跌1.53%，卖空量成交30.7万股，较上一交易日减少6.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163306a44a6c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163306a44a6c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01477","01672","BK1191","BK1515"],"gpt_icon":0},{"id":"1173832741","title":"歌礼制药（1672）更新2026年2月股份变动月报表，已发行股份增至约10.68亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1173832741","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173832741?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:16","pubTimestamp":1772522203,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年3月3日发布截至2026年2月28日的股份变动月报表。公告显示，公司法定股本本月未变动，仍为70亿股授权股本，每股面值0.0001美元，总额700,000美元。报告期内，公司已发行股份数由上月底的991,874,320股增至1,061,130,320股，期间变动主要来自于2月10日完成的配售发行，涉及69,256,000股新股。根据公告，报告期内无来自股份期权的新增发行或行使，未见有其他股份期权或可转换证券的变动。截至报告期末，公司已发行股份总数增至约10.68亿股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"2616833947","title":"歌礼制药-B03月02日主力净流出59.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616833947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616833947?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439327,"startTime":"0","endTime":"0","summary":"03月02日, 歌礼制药-B股价跌3.17%，报收15.26元，成交金额2504.9万元，换手率0.15%，振幅4.19%，量比0.75。歌礼制药-B今日主力资金净流出59.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌9.60%，主力资金累计净流出313.9万元；近20日主力资金累计净流入2861.2万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161650a730aeb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161650a730aeb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1191","BK1161","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"2614031698","title":"歌礼制药-B02月25日主力净流入129.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614031698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614031698?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007330,"startTime":"0","endTime":"0","summary":"02月25日, 歌礼制药-B股价涨2.10%，报收16.56元，成交金额2593.2万元，换手率0.15%，振幅4.69%，量比0.65。歌礼制药-B今日主力资金净流入129.4万元，上一交易日主力净流出422.2万元。该股近5个交易日上涨0.85%，主力资金累计净流出492.3万元；近20日主力资金累计净流入3672.4万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161715a71d4773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161715a71d4773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01477","BK1161","01672","BK1191","BK1515"],"gpt_icon":0},{"id":"2613753493","title":"每日卖空追踪 | 歌礼制药-B 02月23日卖空量成交12.8万股，卖空比例为6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613753493?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835423,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间02月23日，跌4.47%，卖空量成交12.8万股，较上一交易日增加2.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163247a4be7cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163247a4be7cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","01672","BK1574","BK1191","BK1161"],"gpt_icon":0},{"id":"2613753463","title":"歌礼制药-B02月23日主力净流出370.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613753463?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834533,"startTime":"0","endTime":"0","summary":"02月23日, 歌礼制药-B股价跌4.47%，报收16.87元，成交金额3267.1万元，换手率0.18%，振幅6.12%，量比0.41。歌礼制药-B今日主力资金净流出370.8万元，上一交易日主力净流入174万元。该股近5个交易日上涨1.79%，主力资金累计净流入469.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4186.5万元，其中净流入天数为14日。该股主力净额占比0.02%，港股市场排名2610/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161713a71558a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161713a71558a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","BK1515","01477","BK1191","BK1574"],"gpt_icon":0},{"id":"2613875346","title":"歌礼制药-B盘中异动 股价大跌5.15%报16.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613875346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613875346?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:17","pubTimestamp":1771813070,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘10时17分，歌礼制药-B股票出现波动，股价快速下跌5.15%。截至发稿，该股报16.750港元/股，成交量66.3万股，换手率0.06%，振幅5.04%。资金方面，该股资金流入200.587万港元，流出793.559万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.72%。其相关个股中，云康集团、中基长寿科学、和铂医药-B涨幅较大，振幅较大的相关个股有云康集团、百奥赛图-B、康宁杰瑞制药-B，振幅分别为17.14%、7.98%、7.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223101750a714847c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223101750a714847c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1574","BK1191","01477","01672"],"gpt_icon":0},{"id":"2612325192","title":"歌礼制药-B盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612325192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612325192?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:42","pubTimestamp":1771555346,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘10时42分，歌礼制药-B股票出现波动，股价急速拉升5.42%。截至发稿，该股报17.500港元/股，成交量109.7万股，换手率0.10%，振幅6.02%。资金方面，该股资金流入567.175万港元，流出267.51万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，永泰生物-B、歌礼制药-B、基石药业-B涨幅较大，振幅较大的相关个股有来凯医药-B、中慧生物-B、诺诚健华，振幅分别为9.44%、8.44%、7.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010422697a68a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010422697a68a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","01672","BK1515","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"2611596900","title":"智通特供｜南向1.41万亿“压舱” 韩国散户“点火”——港股迎来定价权分层时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2611596900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611596900?lang=zh_cn&edition=full","pubTime":"2026-02-13 09:45","pubTimestamp":1770947145,"startTime":"0","endTime":"0","summary":"2025年至2026年初，港股市场迎来两股特征迥异、但方向共振的增量资金——内地南向资金以1.41万亿港元的年度净买入刷新历史纪录，成为港股定价权的核心构建者；韩国散户资金则以“东学蚂蚁”式的集中押注、高杠杆交易及对前沿科技的极致追逐，在港股边缘地带掀起结构性浪潮。截至2025年末，南向资金累计净流入达5.11万亿港元，2025年当年净买入1.41万亿港元，规模接近2022至2024年三年总和。持仓市值突破6.3万亿港元，占港股总市值比重升至12.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0054450605.USD","LU0259732245.USD","LU2506951792.HKD","LU0359201885.HKD","LU0449509016.USD","BYDDY","01672","LU1720050803.USD","LU0588545490.SGD","LU0289960550.SGD","LU0143863784.USD","LU0543330566.HKD","002594","LU0229945570.USD","LU1813983027.USD","VT","SG9999015978.USD","LU0511384066.AUD","LU2153592121.USD","LU0588545730.USD","LU0348805143.USD","LU0708995583.HKD","BK1500","LU0819121731.USD","LU2328871848.SGD","LU1868837722.USD","LU0359202008.SGD","LU2778985437.USD","81211","LU0143863198.USD","BK1594","LU0505663152.USD","BK1161","LU2476274308.USD","LU0165289439.USD","BK1539","SG9999015945.SGD","SG9999015986.USD","LU0509642566.USD","LU0269904917.USD","HYDD.SI","LU0540923850.HKD","LU2097828805.USD","06160","VXUS","LU0871576103.HKD","BK1610","LU0561508036.HKD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":0.1907},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.337},{"period":"6month","weight":0.6306},{"period":"1year","weight":1.242},{"period":"ytd","weight":0.4802}],"compareEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.0678},{"period":"3month","weight":-0.0336},{"period":"6month","weight":-0.045},{"period":"1year","weight":0.0582},{"period":"ytd","weight":-0.0265}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.146882},{"month":2,"riseRate":0.75,"avgChangeRate":0.100059},{"month":3,"riseRate":0.375,"avgChangeRate":-0.042727},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.428571,"avgChangeRate":0.007612},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.024499},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032162},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.037953},{"month":9,"riseRate":0.125,"avgChangeRate":-0.072967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023171},{"month":11,"riseRate":0.875,"avgChangeRate":0.185422},{"month":12,"riseRate":0.5,"avgChangeRate":0.087327}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}